CARL SCHUSTER OF RUDEN MCCLOSKY AND SHELDON ANDERSON OF NORTHERN TRUST RECEIVE HONORS FROM JUVENILE DIABETES RESEARCH FOUNDATION, SOUTH FLORIDA CHAPTER
June 11, 2004Gala Reaches Fundraising Goal for Juvenile Diabetes Research
Fort Lauderdale, FL Carl Schuster, President and Managing Director of the Florida law firm Ruden McClosky and Sheldon Anderson, President of Northern Trust, Miami-Dade, each were presented with the Commitment to the Dream Award on Saturday, June 5th at the First Annual More Than A Dream Gala of the South Florida Chapter of the Juvenile Diabetes Research Foundation (JDRF). The black tie evening attended by more than 240 JDRF supporters took place at the Westin Diplomat Resort and Spa in Hollywood, FL and raised $100,000 for research to find a cure for juvenile diabetes.
'Both Mr. Schuster and Mr. Anderson, and their respective companies have been tremendous pillars of support for the South Florida Chapter of JDRF. I'm so pleased that we had the opportunity to honor each of them for their consistent efforts of support on behalf of the estimated 17 million Americans living with diabetes,' said Paul Withrow, Executive Director of JDRF.
The evening opened with a silent auction and reception followed by dinner, a live auction, and a 'Fund-A-Cure' drive in which donations were made directly to fund a diabetes research grant in the name of Mr. Schuster and Mr. Anderson. Television news personality Tony Segreto of NBC6 was Master of Ceremonies.
Jan Nassivera, Chairman of the Board of the South Florida Chapter of JDRF and a Type 1 diabetic for the past twenty-six years said, 'It was a wonderful evening. We honored good friends and were able to truly celebrate our commitment to the mission of the Juvenile Diabetes Research Foundation.'
JDRF, the leading charitable funder and advocate of juvenile (Type 1) diabetes research worldwide, was founded in 1970 by the parents of children with juvenile diabetes a disease which strikes children suddenly, makes them insulin-dependent for life, and carries the constant threat of devastating complications. Since inception, JDRF has provided more than $700 million in direct funding to diabetes research. More than 85 percent of JDRF's expenditures directly support research and research-related education. JDRF's mission is constant: to find a cure for diabetes and its complications through the support of research. For more information, visit the JDRF web site at www.jdrf.org or call 954-565-4775.
